155 related articles for article (PubMed ID: 2481883)
41. [Hemodilution in peripheral arterial occlusive disease].
Becsi C; Wehofer D; Weidinger P
Vasa Suppl; 1988; 26():113-5. PubMed ID: 2462284
[No Abstract] [Full Text] [Related]
42. Hemorheology and walking of peripheral arterial occlusive diseases patients during treatment with Ginkgo biloba extract.
Li AL; Shi YD; Landsmann B; Schanowski-Bouvier P; Dikta G; Bauer U; Artmann GM
Zhongguo Yao Li Xue Bao; 1998 Sep; 19(5):417-21. PubMed ID: 10375799
[TBL] [Abstract][Full Text] [Related]
43. A double-blind trial of Dextran-haemodilution vs. placebo in claudicants.
Ernst E; Kollar L; Matrai A
J Intern Med; 1990 Jan; 227(1):19-24. PubMed ID: 1688913
[TBL] [Abstract][Full Text] [Related]
44. Haemodilution induced by hydroxyethyl starches 130/0.4 is similar in septic and non-septic patients.
Meyer P; Pernet P; Hejblum G; Baudel JL; Maury E; Offenstadt G; Guidet B
Acta Anaesthesiol Scand; 2008 Feb; 52(2):229-35. PubMed ID: 18034867
[TBL] [Abstract][Full Text] [Related]
45. Placebo-controlled, double-blind study of haemodilution in peripheral arterial disease.
Ernst E; Matrai A; Kollar L
Lancet; 1987 Jun; 1(8548):1449-51. PubMed ID: 2885450
[TBL] [Abstract][Full Text] [Related]
46. [Therapy of arterial occlusive diseases. The effect of bencyclan in trained patients with peripheral arterial occlusive disease (Double-blind study)].
Battke K; Buchwalsky R; Barmeyer J; Hoffmann G; Reindell H
Fortschr Med; 1978 Jul; 96(26-27):1381-6. PubMed ID: 669532
[No Abstract] [Full Text] [Related]
47. [Hemorheologic therapy in peripheral arterial occlusive disease].
Kiesewetter H; Jung F
Fortschr Med; 1984 Oct; 102(37):921-4. PubMed ID: 6500451
[TBL] [Abstract][Full Text] [Related]
48. Isovolemic hemodilution alters the ratio of whole-body to large-vessel hematocrit (F-cell ratio). A prospective, randomized study comparing the volume effects of hydroxyethyl starch 200,000/0.62 and albumin.
Haller M; Brechtelsbauer H; Akbulut C; Fett W; Briegel J; Finsterer U
Infusionsther Transfusionsmed; 1995 Apr; 22(2):74-80. PubMed ID: 7540445
[TBL] [Abstract][Full Text] [Related]
49. [Hemodilution].
Landgraf H
Wien Med Wochenschr; 1986; 136 Spec No():36-40. PubMed ID: 3548090
[TBL] [Abstract][Full Text] [Related]
50. [Clinical results after hemodilution with hydroxyethyl starch in pregnancy].
Heilmann L
Z Geburtshilfe Perinatol; 1989; 193(5):219-25. PubMed ID: 2479180
[TBL] [Abstract][Full Text] [Related]
51. [Anti-thixotropic therapy in arterial occlusive disorders: What is the effectiveness of "rheological procedures" in the presence of persisting obliterations?].
Schmid-Schönbein H
Wien Med Wochenschr; 1985 Aug; 135(15-16):368-79. PubMed ID: 4060740
[TBL] [Abstract][Full Text] [Related]
52. [Multi-distributed ischemia and degree of hemorrheological changes].
Sergio G; Artale F; Francisci A; Perego MA
Ric Clin Lab; 1983; 13 Suppl 3():427-30. PubMed ID: 6673025
[TBL] [Abstract][Full Text] [Related]
53. Minimal walking distance following exercise treatment in patients with arterial occlusive disease.
Rosetzsky A; Struckmann J; Mathiesen FR
Ann Chir Gynaecol; 1985; 74(6):261-4. PubMed ID: 4096478
[TBL] [Abstract][Full Text] [Related]
54. [Can normovolemic hemodilution really modify blood flow in the limbs?].
Guerrini M; Pieragalli D; Acciavatti A; Cappelli R; Pecchi S; Forconi S; Di Perri T
Ric Clin Lab; 1983; 13 Suppl 3():439-44. PubMed ID: 6673027
[TBL] [Abstract][Full Text] [Related]
55. [Hemodilution in acute arterial circulatory disorders of the retina].
Arend O; Hoberg A; Bertram B; Reim M; Wolf S
Acta Med Austriaca; 1991; 18 Suppl 1():66-8. PubMed ID: 1719735
[TBL] [Abstract][Full Text] [Related]
56. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
Mangiafico RA; Malatino LS; Santonocito M; Messina R; Attinà T; Dell'Arte S; Sarnataro F
Int J Clin Pharmacol Ther; 1999 Jul; 37(7):347-51. PubMed ID: 10442509
[TBL] [Abstract][Full Text] [Related]
57. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
Nenci GG; Gresele P; Ferrari G; Santoro L; Gianese F;
Thromb Haemost; 2001 Nov; 86(5):1181-7. PubMed ID: 11816704
[TBL] [Abstract][Full Text] [Related]
58. Haemodilution in patients with peripheral arterial occlusive disease.
Kiesewetter H; Jung F; Erdlenbruch W; Wenzel E
Int Angiol; 1992; 11(3):169-75. PubMed ID: 1281205
[TBL] [Abstract][Full Text] [Related]
59. [Effect of hemodilution with plasma protein solution and hydroxyethyl starch on plasma fibronectin].
Khosropour R; Graninger W; Lackner F
Anasth Intensivther Notfallmed; 1984 Aug; 19(4):175-8. PubMed ID: 6208807
[TBL] [Abstract][Full Text] [Related]
60. Beta blockade and intermittent claudication.
Lepäntalo M
Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
